ODF Coating Challenges for High-Viscosity and High-Load Formulations
Share
Introduction
With the rise of oral dissolvable films (ODFs) in both pharmaceutical and functional food sectors, the demand for high-dose, multi-ingredient formulations is growing rapidly. From nutrient-dense vitamin films to drug-loaded therapeutic films, one key question emerges: how can companies maintain dose uniformity while stably coating high-viscosity materials?
1. Technical Barriers in High-Viscosity Coating
- Poor flowability: Thick formulations can lead to uneven coating when traditional methods are used.
- Drying inefficiency: High solid content slows down water evaporation, increasing the risk of residual moisture.
- Dose uniformity risks: High load concentrations make batch-to-batch consistency more difficult to control.
2. Common Industry Pain Points
- Slot-die coating struggles with high-viscosity materials, causing nozzle clogging and poor layer uniformity.
- Drying speed vs. energy usage: high heat may degrade temperature-sensitive actives.
- Scaling up from lab to production often leads to significant formulation and performance deviations.
3. HUANGHAI’s Solution
- Patented Scraper Coating Technology: Adjustable micro-gap scraper ensures consistent spread of thick formulations.
- Gradient Hot-Air Drying: Optimized airflow design boosts drying efficiency while protecting active ingredients.
- Scalable Equipment Portfolio: MJ150-L for lab/pilot scale; MJ150 for high-volume commercial production.
4. Regulatory & Quality Value
- Meets dose uniformity and dissolution standards under Chinese Pharmacopeia, USP, and EP.
- Stable process reduces batch variation, facilitating registration and export compliance.
- Ensures high-performance membranes across nutraceutical and pharmaceutical segments.
Recommended Equipment
Conclusion
High-viscosity and high-load formulations represent a promising future for ODF development, but they demand more sophisticated coating strategies. With our scraper-based coating and energy-efficient drying systems, HUANGHAI delivers robust, scalable solutions to help you transition from lab to launch with confidence.
*Features Huanghai's exclusive patented hot-air drying technology (Patent No. CN201668734U) ensuring uniform bottom-up heating.
Frequently Asked Questions
Q: What is the difference between an ODF film and a transdermal patch?
A: Oral Dissolving Films (ODF) are placed on or under the tongue and dissolve within seconds to minutes, delivering APIs directly through the oral mucosa or via swallowing. Transdermal patches adhere to the skin and deliver APIs through the dermal layers into systemic circulation over hours to days. Despite different delivery routes, both are manufactured using similar solvent-cast film coating processes. Huanghai's MJ150 ODF machine supports both applications on a single platform with approximately 2 working days of changeover time.
Q: What production output can I expect from a Huanghai ODF machine?
A: The MJ150 produces 20,000 films/hour at commercial scale. The MJ150-L targets R&D and pilot production at 8,000–10,000 films/hour. For fully integrated lines, pair either machine with the MJF180 automatic cutting and packaging system (11,900 films/hr) or the more affordable EZ320 (9,000 films/hr). A complete MJ150 + MJF180 line can produce over 150 million finished pouches annually on a single-shift basis. Contact us for pricing and configuration details.
Q: What drying technology does Huanghai use for ODF production?
A: Huanghai uses patented gradient hot-air drying (Patent CN201668734U), which applies a smooth progressive temperature drop rather than stepwise oven zones used by competitors. This results in more uniform film thickness, reduced edge curl, and better API distribution across the film web. An optional far-infrared heating module adds 20–30% drying efficiency for solvent-based formulations. This patented drying system is one of the key technical advantages that justifies Huanghai's position as the preferred ODF equipment supplier to Sinopharm, Shanghai Pharma, and Fosun Pharma.
Q: What are the GMP requirements for ODF production equipment?
A: ODF manufacturing equipment must comply with cGMP (21 CFR Parts 210/211) for US market products, and equivalent standards (EU GMP Annex 1, ChGMP) for other markets. Key requirements: material contact surfaces must be 316L stainless steel or equivalent; CIP/SIP capability or documented cleaning validation; data integrity controls meeting ALCOA+ principles (audit trails, access control). Huanghai ODF machines meet these standards—all product contact surfaces use pharmaceutical-grade materials, and the control system includes operator access logs and parameter change records. Request our GMP compliance documentation.
Q: Can Huanghai machines produce stripe-coated or multi-formula ODF films?
A: Yes. Huanghai holds a patent for multi-formula stripe coating (Patent CN117323228A), enabling two different API formulations to be applied side-by-side in a single coating pass. This eliminates the need for multiple coating/drying cycles when producing combination-drug ODF products. Competitors require manual multi-layer coating with drying intervals between each formula. This capability is particularly valuable for fixed-dose combination products (e.g., dual-API ODFs for cardiovascular or CNS indications) where coating efficiency directly impacts production economics.
Verify our compliance credentials. Shanghai Huanghai Pharmaceutical Instruments holds FDA / GMP / ISO certifications across our pharma testing and ODF manufacturing equipment lines. View our Certifications →
Explore Complete ODF & TDDS Manufacturing Solutions
Huanghai offers end-to-end ODF film production lines — from lab-scale R&D (BY-300A / MJ150-L) to commercial manufacturing (MJ150). GMP-certified and 21 CFR Part 11 compliant.